XML 14 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
REVENUES:    
Operating Revenues – equipment sales and related services$ 260,231$ 368,201$ 841,158$ 958,929
Operating Revenues – cryobanking and related services80,67685,080235,357258,956
Total Revenues340,907453,2811,076,5151,217,885
Cost of equipment sales and related services136,166174,014445,453516,304
Cost of cryobanking and related services13,21011,72830,10426,626
Total Cost of Sales149,376185,742475,557542,930
Gross Profit191,531267,539600,958674,955
OPERATING EXPENSES:    
Research and development-equipment sales and related services591,043642,1431,853,3502,166,121
Research and development-cryobanking and related services46,00852,587143,074155,143
Total Research and Development Expenses637,051694,7301,996,4242,321,264
Selling, general, and administrative- equipment sales and related services639,894651,6392,903,7961,950,852
Selling, general, and administrative- cryobanking and related services175,658206,035481,544534,930
Total Selling, General & Administrative Expenses815,552857,6743,385,3402,485,782
Total Operating Expenses1,452,6031,552,4045,381,7644,807,046
Loss from Operations(1,261,072)(1,284,865)(4,780,806)(4,132,091)
Dividend income-investment portfolio645,792635,6781,719,3451,722,944
Realized gains on sale of securities and options, net253,5052,370,5106,277,5529,936,557
Mark to market adjustments on short sales of options(6,608,910)2,735,102(12,764,473)(2,355,785)
Other revenues3,0933,0419,2819,124
Interest expense(29,769)(20,323)(141,677)(35,506)
Administrative expense relating to portfolio investments(31,444)(35,227)(101,153)(101,244)
Total Other (Loss) Income(5,767,733)5,688,781(5,001,125)9,176,090
(Loss) Income before Income Taxes(7,028,805)4,403,916(9,781,931)5,043,999
Income Tax (Benefit) Expense(2,845,136)1,799,112(4,087,480)2,343,258
Net (Loss) Income(4,183,669)2,604,804(5,694,451)2,700,741
Net Income (Loss)(4,183,669)2,604,804(5,694,451)2,700,741
Unrealized (Loss )Gain on Securities Held for Sale, Net of Deferred Income Taxes(3,710,012)3,829,575(2,958,476)(292,161)
Comprehensive (Loss) Income$ (7,893,681)$ 6,434,379$ (8,652,927)$ 2,408,580
Weighted average number of shares outstanding – basic and diluted (in Shares)4,219,0264,232,6914,223,5044,240,753
Net (Loss) Income per common equivalent share – basic and diluted (in Dollars per share)$ (0.99)$ 0.62$ (1.35)$ 0.64
Dividends paid per common share (in Dollars per share) $ 0.25$ 0.15$ 0.35